Global Kidney Care Podcast Provided by ISN

Every year, the ISN Continuing Medical Education (CME) Program brings essential teaching and training to some 14,000 doctors and healthcare practitioners in the emerging world. This Program supports the conceptual design of local and regional meetings in resource-low countries by contributing to the organization of the meeting and helping arrange faculty for the meeting. 

This episode is hosted by Urmila Anandh (India), a member CME Program Committee and she is joined by Rümeyza Turan Kazancioglu (Turkey), Adrian Liew (Singapore) and Jaime Restrepo (Colombia) to discuss the activities and initiatives of the CME Programs Committee. They discuss how the committee serves the ISN and the global nephrology world. 

Haemodialysis (HD) requires safe and effective anticoagulation to prevent clot formation within the extracorporeal circuit during dialysis treatments to enable adequate dialysis and minimise adverse events, including major bleeding. Low molecular weight heparin (LMWH) may provide a more predictable dose, reliable anticoagulant effects and be simpler to administer than unfractionated heparin (UFH) for HD anticoagulation, but may accumulate in the kidneys and lead to bleeding. in this latest episode fo the podcast Edmund Chung, Knowledge and Information Decimation Editor of the Cochrane Kidney Transplant Group. Edmund is Joined by the lead author on this article Patricia Natale Sydney School of Public Health, The University of Sydney. 

For this episode of the Global Kidney Care Podcast, Jonathan Barratt, MD, MSc, PhD is Professor of Renal Medicine, Department of Cardiovascular Sciences at the University of Leicester and Richard Lafayette, MD, FACP is a Nephrologist and Professor of Medicine at the Division of Nephrology Department of Medicine, Stanford University discuss the changing landscape in IgAN and disease modification approaches. 

This podcast is supported by Vera Therapeutics 

Recorded live at the WCN’ 24 in Buenos Aires Argentina this conversation focuses on the ISN Educational Ambassadors (EA) Program. 

Renal centers around the world can apply for support of the Educational Ambassadors (EA) Program and receive expert guidance and hands-on training to advance new initiatives, skills or services, and community-based research and screening programs.

EA Program Committee member Titi Chen, Nephrologist and Transplant physician from the University of Sydney, Australia, leads a discussion on the purpose and impact of the EA Program with its outgoing chair Gavin Dreyer, Nephrologist, King’s College London, UK, and program participants Lázaro Cobiellas Carballo, Nephrologist, University of Medical Sciences in Holguin, Cuba, Juan Santacruz Mancheno, Nephrologist from the Clínica de los riñones Menydial, Ecuador and Bernardo Moguel, Instituto Nacional de Cardiología Ignacio Chavez, Mexico. 

This latest episode of the Global Kidney Care Podcast is an effort of the ISN, ISPD, and Arbor Research Collaborative for Health (the coordinating center for the DOPPS family of studies). This episode is focused on PDOPPS, our international study of practice patterns and outcomes of peritoneal dialysis patients. The conversation is led by Roberto Pecoits-Filho, DOPPS Program Scientific Director and is joined by the president of the ISPD Edwina Brown from the Imperial College Renal & Transplant Centre, Jenny Shen from the Harbor-UCLA Medical Center and Jeffrey Perl from St Michael’s Hospital in Toronto and the Principal Investigator of PDOPPS.

Helen Hurst, Ana Elizabeth Figueiredo and Rachael Walker members of the ISN's Kidney Health Professionals Working Group discuss shared decision making. This was recorded in person during the ISN's World Congress of Nephrology 2024 in Buenos Aires, Argentina. This podcast is supported by Baxter. 

Fatigue is a common and debilitating symptom amongst people with kidney failure but remains under appreciated and understudied. Interventions to address fatigue in people with kidney failure requiring dialysis are lacking, highlighted by the lack of recommendations on managing fatigue in clinical practice guidelines. A Cochrane review was published in 2023 summarizing the benefits and harms of pharmacological and non-pharmacological interventions for fatigue in people on dialysis. On this podcast, the review’s first author Dr Patrizia Natale joins us to discuss the study’s findings. 

World Kidney Day (WKD) is observed every year on the Second Thursday of March. In 2023, it falls on March 14th and aims to advocate for Kidney Health for All! Professor Alessandro Balducci, co-chair of the WKD Joint Steering Committee, is joined in this episode by WKD Joint Steering Committee members Dr. Dina Abdellatif, Dr. Ricardo Correa-Rotter, and Dr. Katherine Tuttle, the Executive Director for Research at Providence Inland Northwest Health. The WKD Joint Steering Committee has declared WKD 2024 as “Advancing equitable access to care and optimal medication practice.” Their conversation covers the goals of WKD, raising awareness about the importance of ensuring equitable access to appropriate treatment and care for people living with kidney disease, in order to improve their quality of life and delay the progression of the disease. 

Recently the International Society of Nephrology (ISN) and the Polycystic Kidney Disease Foundation (PKDF) held a joint webinar to discuss and explore the significant impact of health disparities on the outcomes for patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD). In the latest episode of the Global Kidney Care Podcast, Dr. Maria E. Diaz-Gonzalez de Ferris, Dr. Sambhavi Krishnamoorthy and patient advocate Funke Ojuri continue the conversation on Health disparities that are often driven by socioeconomic, racial, and geographic factors and how they play a crucial role in shaping the progression of ADPKD and its associated complications. 

This re-published episode was originally published in 2015 and is hosted by Jack Milln and he takes a look at Uganda and how kidney disease has affected the lives of the people in this country. It also touches on the hardships of relying on expensive treatment options in a resource-poor country. 

The developing countries of sub-Saharan Africa are under threat by an emerging epidemic of kidney disease. Populations are no longer solely affected by ‘diseases of poverty’ such as HIV/TB/malaria but also ‘diseases of affluence’ such as diabetes and hypertension. Disease is often asymptomatic until end-stage disease develops requiring expensive treatment options such as transplant or dialysis.

In this episode you will here from patients in Uganda about how kidney disease has affected their lives, and the hardships of relying on expensive treatment options in a resource-poor country.